Effect of silver lactate and silver sulfadiazine on experimental burn wound sepsis.
D000481:Allantoin / Q000627:therapeutic use; D000818:Animals; D002056:Burns / Q000150:complications*; D007773:Lactates / Q000627:therapeutic use*; D011552:Pseudomonas Infections / Q000188:drug therapy*; D051381:Rats; D011919:Rats, Inbred Strains; D018805:Sepsis / Q000188:drug therapy*; D012834:Silver / Q000627:therapeutic use*; D012867:Skin / Q000382:microbiology; D013411:Sulfadiazine / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use; D014946:Wound Infection / Q000209:etiology* / Q000382:microbiology
D007773:Lactates; D013449:Sulfonamides; D013411:Sulfadiazine; D000481:Allantoin; D012834:Silver